179 related articles for article (PubMed ID: 29523771)
41. Targeting syndecan-1: new opportunities in cancer therapy.
Yang Z; Chen S; Ying H; Yao W
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C29-C45. PubMed ID: 35584326
[TBL] [Abstract][Full Text] [Related]
42. Sulfated syndecan 1 is critical to preventing cellular senescence by modulating fibroblast growth factor receptor endocytosis.
Kang D; Jung SH; Lee GH; Lee S; Park HJ; Ko YG; Kim YN; Lee JS
FASEB J; 2020 Aug; 34(8):10316-10328. PubMed ID: 32530114
[TBL] [Abstract][Full Text] [Related]
43. Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
Shi S; Zhong D; Xiao Y; Wang B; Wang W; Zhang F; Huang H
Oncotarget; 2017 Jun; 8(25):40922-40934. PubMed ID: 28422726
[TBL] [Abstract][Full Text] [Related]
44. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.
Bode L; Salvestrini C; Park PW; Li JP; Esko JD; Yamaguchi Y; Murch S; Freeze HH
J Clin Invest; 2008 Jan; 118(1):229-38. PubMed ID: 18064305
[TBL] [Abstract][Full Text] [Related]
45. Syndecan-1 facilitates breast cancer metastasis to the brain.
Sayyad MR; Puchalapalli M; Vergara NG; Wangensteen SM; Moore M; Mu L; Edwards C; Anderson A; Kall S; Sullivan M; Dozmorov M; Singh J; Idowu MO; Koblinski JE
Breast Cancer Res Treat; 2019 Nov; 178(1):35-49. PubMed ID: 31327090
[TBL] [Abstract][Full Text] [Related]
46. The niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical development.
Wang Q; Yang L; Alexander C; Temple S
PLoS One; 2012; 7(8):e42883. PubMed ID: 22936997
[TBL] [Abstract][Full Text] [Related]
47. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
Kim SY; Choi EJ; Yun JA; Jung ES; Oh ST; Kim JG; Kang WK; Lee SH
Int J Med Sci; 2015; 12(2):92-9. PubMed ID: 25589885
[TBL] [Abstract][Full Text] [Related]
48. Glycosaminoglycans are involved in bacterial adherence to lung cells.
Rajas O; Quirós LM; Ortega M; Vazquez-Espinosa E; Merayo-Lloves J; Vazquez F; García B
BMC Infect Dis; 2017 May; 17(1):319. PubMed ID: 28464847
[TBL] [Abstract][Full Text] [Related]
49. Shedding of Syndecan-1/CXCL1 Complexes by Matrix Metalloproteinase 7 Functions as an Epithelial Checkpoint of Neutrophil Activation.
Gill SE; Nadler ST; Li Q; Frevert CW; Park PW; Chen P; Parks WC
Am J Respir Cell Mol Biol; 2016 Aug; 55(2):243-51. PubMed ID: 26934670
[TBL] [Abstract][Full Text] [Related]
50. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract][Full Text] [Related]
51. Syndecan-1 regulates dendritic cell migration in cutaneous hypersensitivity to haptens.
Averbeck M; Kuhn S; Bühligen J; Götte M; Simon JC; Polte T
Exp Dermatol; 2017 Nov; 26(11):1060-1067. PubMed ID: 28453867
[TBL] [Abstract][Full Text] [Related]
52. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
53. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.
Qing Q; Zhang S; Chen Y; Li R; Mao H; Chen Q
J Cell Mol Med; 2015 Jun; 19(6):1366-74. PubMed ID: 25702768
[TBL] [Abstract][Full Text] [Related]
54. Molecular functions of syndecan-1 in disease.
Teng YH; Aquino RS; Park PW
Matrix Biol; 2012 Jan; 31(1):3-16. PubMed ID: 22033227
[TBL] [Abstract][Full Text] [Related]
55. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
[TBL] [Abstract][Full Text] [Related]
56. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
[TBL] [Abstract][Full Text] [Related]
57. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
58. Role of heparan sulfate proteoglycan (syndecan-1) on the renal epithelial cells during calcium oxalate monohydrate crystal attachment.
Chikama S; Iida S; Inoue M; Kawagoe N; Tomiyasu K; Matsuoka K; Noda S; Takazono I
Kurume Med J; 2002; 49(4):201-10. PubMed ID: 12652971
[TBL] [Abstract][Full Text] [Related]
59. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
60. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
